Skip to main content

Iothalamate Dosage

Applies to the following strengths: 17.2%; 30%; 60%; 66.8%; 43%

Usual Adult Dose for:

Additional dosage information:

Usual Adult Dose for Computed Tomography

Urography, cerebral angiography, peripheral arteriography, venography, arthrography, direct cholangiography, endoscopic retrograde cholangiopancreatography

Contrast enhancement of computed tomographic brain images, cranial computerized angiotomography, intravenous digital subtraction angiography and arterial digital subtraction angiography

Computed tomographic scans performed for detection and evaluation of lesions in the liver, pancreas, kidneys, abdominal aorta, mediastinum, abdominal cavity and retroperitoneal space.

Retrograde cystography and cystourethrography

Renal Dose Adjustments

Advanced Renal Disease: Iodinated contrast media should be used with caution, and only when the needed, since excretion of the medium may be impaired.

Liver Dose Adjustments

Data not available


Serious adverse reactions have been reported due to the inadvertent intrathecal administration of iodinated contrast media that are not indicated for intrathecal use. These serious adverse reactions include: death, convulsions, cerebral hemorrhage, coma, paralysis, arachnoiditis, acute renal failure, cardiac arrest, seizures, rhabdomyolysis, hyperthermia, and brain edema. Special attention must be given to ensure that this drug product is not administered intrathecally.

The product CYSTO-CONRAY II- iothalamate meglumine injection is not approved for intravascular administration.

Consult WARNINGS section for additional precautions.


Data not available

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.